z-logo
open-access-imgOpen Access
The impact of vedolizumab on COVID-19 outcomes among adult IBD patients in the SECURE-IBD registry
Author(s) -
Manasi Agrawal,
Xian Zhang,
Erica J. Brenner,
Ryan C. Ungaro,
Michael D. Kappelman,
JeanFrédéric Colombel
Publication year - 2021
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/svtt-eh21
Subject(s) - vedolizumab , medicine , covid-19 , virology , inflammatory bowel disease , disease , infectious disease (medical specialty) , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom